# US 2008/0076749 A1 · Stabilizing compositions for antibiotics and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076749 A1
- Document ID: US20080076749A1
- Status: Published application
- Kind: A1
- Application number: 11/902,925
- Filed: 2007-09-26
- Published: 2008-03-27
- Earliest claimed: 2006-09-26
- Assignees: Taro Pharmaceuticals U.S.A., Inc.
- Inventors: Shen Gao; Daniel Moros; Satish Asotra
- Web page: https://patentgrep.com/patent/US20080076749A1

## CPC

- A61K 31/43: Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula [IMAGE cpc-sch-A61K-0952.gif], e.g. penicillins, penems
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 31/424: condensed with heterocyclic ring systems, e.g. clavulanic acid
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is directed to improved liquid antibiotic formulations. In some embodiments, the present invention is directed to a composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition has less than about 5% water (w/v).

## Claims

### Claim 1

1) A pharmaceutical composition comprising an antibiotic in a liquid comprising a triglyceride, wherein the composition has less than about 5% water (w/v).

### Claim 2 (depends on 1)

2) The composition of claim 1, wherein the antibiotic is selected from the group consisting of a penicillin, a cephalosporin, a carbapenem, and mixtures thereof.

### Claim 3 (depends on 1)

3) The composition of claim 1, wherein the antibiotic is a penicillin selected from the group consisting of penicillin G, penicillin V, methicillin, nafcillin, oxacillin, cloxacillin, dicloacllin, ampicillin, amoxicillin, carbenicillin, ticarcillin, piperacillin, meziocillin, aziocillin, and mixtures thereof.

### Claim 4 (depends on 1)

4) The composition of claim 1, wherein the triglyceride is selected from the group consisting of short chain triglycerides, medium chain triglycerides, and long chain triglycerides.

### Claim 5 (depends on 1)

5) The composition of claim 1, wherein the composition has less than about 1% water (w/v).

### Claim 6 (depends on 1)

6) The composition of claim 1, wherein the composition has less than about 0.1% water (w/v).

### Claim 7 (depends on 1)

7) The composition of claim 1, further comprising a β-lactamase inhibitor.

### Claim 8 (depends on 7)

8) The composition of claim 7, wherein the β-lactamase inhibitor is clavulanic acid.

### Claim 9 (depends on 8)

9) The composition of claim 8, further comprising amoxicillin.

### Claim 10 (depends on 9)

10) The composition of claim 9, further comprising medium chain triglycerides.

### Claim 11 (depends on 10)

11) The composition of claim 10, wherein the concentration of medium chain triglycerides can be from about 5% (w/v) to about 95% (w/v).

### Claim 12 (depends on 1)

12) The composition of claim 1, wherein the pharmaceutical composition is a dehydrated triglyceride liquid formulation.

### Claim 13

13) A composition consisting essentially of a penicillin and a β-lactamase inhibitor in a liquid comprising medium chain triglycerides, wherein the concentration of triglycerides ranges from about 5% (w/v) to about 95% (w/v), and wherein the composition has less than about 5% water (w/v).

### Claim 14 (depends on 13)

14) The composition of claim 13, wherein the penicillin is amoxicillin and the α-lactamase inhibitor is clavulanic acid.

### Claim 15 (depends on 14)

15) The composition of claim 14, wherein the concentration of amoxicillin ranges from about 50 mg/5 ml to about 800 mg/5 ml and clavulanic acid ranges from about 10 mg/5 ml to about 80 mg/5 ml.

### Claim 16 (depends on 13)

16) The composition of claim 13, wherein the penicillin is stable for at least about ten days when stored at a temperature of about 20° C. to about 25° C.

### Claim 17 (depends on 13)

17) The composition of claim 13, wherein the composition is a dehydrated triglyceride liquid formulation.

### Claim 18

18) A kit comprising (a) a first container comprising a therapeutically effective amount of an antibiotic and (b) a second container comprising a pharmaceutically acceptable carrier, excipient, diluent or combination thereof.

### Claim 19 (depends on 18)

19) The kit of claim 18, wherein at least one container is made of high density polyethylene.

### Claim 20 (depends on 18)

20) The kit of claim 18, wherein the pharmaceutically acceptable carrier is a triglyceride.

### Claim 21 (depends on 18)

21) The kit of claim 18, wherein the therapeutically effective amount of the antibiotic is mixed with a powdered excipient.

### Claim 22 (depends on 21)

22) The kit of claim 21, wherein the powdered excipient has been dried.

### Claim 23

23) A method of treating a microbial infection in a mammal, the method comprising administering a composition comprising an antibiotic in a liquid comprising triglycerides having less than about 5% water (w/v) to a mammal in need thereof.

### Claim 24

24) A composition comprising an antibiotic in a liquid comprising triglycerides, wherein the composition is stable for during a course of antibiotic treatment when stored at a temperature of about 20° C. to about 25° C.

### Claim 25 (depends on 24)

25) The composition of claim 24, wherein the composition is a dehydrated triglyceride liquid formulation.
